Quarterly report · Q2
4188.TEDINET S100S8AF
Period2023-04-01 → 2023-09-30
Filed2023-11-13
StandardIFRS
ConsolidatedYes
Data checks16 of 16 passed
Key figures · 62
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥2.15T | 2023-04-01 → 2023-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥1.09T | 2023-07-01 → 2023-09-30d | Cons. | Revenue IFRS |
| Revenue | ¥4.63T | 2022-04-01 → 2023-03-31 | Cons. | Revenue IFRS (5-year summary) |
| Revenue | ¥2.27T | 2022-04-01 → 2022-09-30 | Cons. | Revenue IFRS |
| Revenue | ¥1.16T | 2022-07-01 → 2022-09-30d | Cons. | Revenue IFRS |
| Operating income | ¥138.6bn | 2023-04-01 → 2023-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥68.9bn | 2023-07-01 → 2023-09-30d | Cons. | Operating profit loss IFRS |
| Operating income | ¥118.4bn | 2022-04-01 → 2022-09-30 | Cons. | Operating profit loss IFRS |
| Operating income | ¥50.3bn | 2022-07-01 → 2022-09-30d | Cons. | Operating profit loss IFRS |
| Profit before tax | ¥130.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥61.3bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥168.0bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss before tax IFRS (5-year summary) |
| Profit before tax | ¥122.0bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss before tax IFRS |
| Profit before tax | ¥46.9bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss before tax IFRS |
| Net income (owners) | ¥67.2bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥24.7bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥96.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent IFRS (5-year summary) |
| Net income (owners) | ¥73.9bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income (owners) | ¥29.1bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss attributable to owners of parent IFRS |
| Net income | ¥94.1bn | 2023-04-01 → 2023-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥38.3bn | 2023-07-01 → 2023-09-30d | Cons. | Profit loss IFRS |
| Net income | ¥135.5bn | 2022-04-01 → 2023-03-31 | Cons. | Profit loss IFRS (5-year summary) |
| Net income | ¥91.5bn | 2022-04-01 → 2022-09-30 | Cons. | Profit loss IFRS |
| Net income | ¥38.2bn | 2022-07-01 → 2022-09-30d | Cons. | Profit loss IFRS |
| Total assets | ¥6.12T | at 2023-09-30 | Cons. | Assets IFRS |
| Total assets | ¥5.77T | at 2023-03-31 | Cons. | Assets IFRS |
| Total assets | ¥6.00T | at 2022-09-30 | Cons. | Total assets IFRS (5-year summary) |
| Total liabilities | ¥3.91T | at 2023-09-30 | Cons. | Liabilities IFRS |
| Total liabilities | ¥3.79T | at 2023-03-31 | Cons. | Liabilities IFRS |
| Net assets / equity | ¥2.21T | at 2023-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.99T | at 2023-03-31 | Cons. | Equity IFRS |
| Net assets / equity | ¥2.04T | at 2022-09-30 | Cons. | Equity IFRS |
| Net assets / equity | ¥1.84T | at 2022-03-31d | Cons. | Equity IFRS |
| Equity (owners) | ¥1.72T | at 2023-09-30 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.56T | at 2023-03-31 | Cons. | Equity attributable to owners of parent IFRS |
| Equity (owners) | ¥1.63T | at 2022-09-30 | Cons. | Equity attributable to owners of parent IFRS (5-year summary) |
| Cash & equivalents | ¥398.8bn | at 2023-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥297.2bn | at 2023-03-31 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥253.7bn | at 2022-09-30 | Cons. | Cash and cash equivalents IFRS |
| Cash & equivalents | ¥245.8bn | at 2022-03-31d | Cons. | Cash and cash equivalents IFRS |
| Operating cash flow | ¥195.7bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Operating cash flow | ¥355.2bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in operating activities IFRS (5-year summary) |
| Operating cash flow | ¥93.2bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in operating activities IFRS |
| Investing cash flow | −¥115.6bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Investing cash flow | −¥247.6bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in investing activities IFRS (5-year summary) |
| Investing cash flow | −¥117.7bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in investing activities IFRS |
| Financing cash flow | ¥6.5bn | 2023-04-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| Financing cash flow | −¥60.8bn | 2022-04-01 → 2023-03-31 | Cons. | Cash flows from used in financing activities IFRS (5-year summary) |
| Financing cash flow | ¥15.6bn | 2022-04-01 → 2022-09-30 | Cons. | Net cash provided by used in financing activities IFRS |
| EPS (basic) | ¥47.25 | 2023-04-01 → 2023-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥17.35 | 2023-07-01 → 2023-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥67.85 | 2022-04-01 → 2023-03-31 | Cons. | Basic earnings loss per share IFRS (5-year summary) |
| EPS (basic) | ¥52.02 | 2022-04-01 → 2022-09-30 | Cons. | Basic earnings loss per share IFRS |
| EPS (basic) | ¥20.44 | 2022-07-01 → 2022-09-30d | Cons. | Basic earnings loss per share IFRS |
| EPS (diluted) | ¥45.22 | 2023-04-01 → 2023-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥16.61 | 2023-07-01 → 2023-09-30d | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥64.99 | 2022-04-01 → 2023-03-31 | Cons. | Diluted earnings loss per share IFRS (5-year summary) |
| EPS (diluted) | ¥49.79 | 2022-04-01 → 2022-09-30 | Cons. | Diluted earnings loss per share IFRS |
| EPS (diluted) | ¥19.58 | 2022-07-01 → 2022-09-30d | Cons. | Diluted earnings loss per share IFRS |
| Equity ratio | 28.2% | at 2023-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 27.1% | at 2023-03-31 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
| Equity ratio | 27.1% | at 2022-09-30 | Cons. | Ratio of owners equity to gross assets IFRS (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 53
| Segment | Item | Period | Value |
|---|---|---|---|
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2023-04-01 → 2023-09-30 | ¥183.8bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2023-04-01 → 2023-09-30 | ¥109.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥73.9bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2023-04-01 → 2023-09-30 | ¥6.7bn |
| Reconciling Itemsreconciling | revenue | 2023-04-01 → 2023-09-30 | −¥129.9bn |
| Reconciling Itemsreconciling | revenue intersegment | 2023-04-01 → 2023-09-30 | −¥129.9bn |
| Reconciling Itemsreconciling | segment profit | 2023-04-01 → 2023-09-30 | −¥6.0bn |
| jpcrp040300-q2r_E00808-000Basic Materialsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥511.3bn |
| jpcrp040300-q2r_E00808-000Basic Materialsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥491.3bn |
| jpcrp040300-q2r_E00808-000Basic Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥20.0bn |
| jpcrp040300-q2r_E00808-000Basic Materialsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | −¥12.6bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥219.4bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥219.3bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥67m |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥32.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥612.6bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥608.2bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥4.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥80.3bn |
| jpcrp040300-q2r_E00808-000MMAreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥144.4bn |
| jpcrp040300-q2r_E00808-000MMAreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥138.4bn |
| jpcrp040300-q2r_E00808-000MMAreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥6.1bn |
| jpcrp040300-q2r_E00808-000MMAreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥1.7bn |
| jpcrp040300-q2r_E00808-000Specialty Materialsreportable segment | revenue | 2023-04-01 → 2023-09-30 | ¥608.3bn |
| jpcrp040300-q2r_E00808-000Specialty Materialsreportable segment | revenue external | 2023-04-01 → 2023-09-30 | ¥582.7bn |
| jpcrp040300-q2r_E00808-000Specialty Materialsreportable segment | revenue intersegment | 2023-04-01 → 2023-09-30 | ¥25.6bn |
| jpcrp040300-q2r_E00808-000Specialty Materialsreportable segment | segment profit | 2023-04-01 → 2023-09-30 | ¥17.1bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue | 2022-04-01 → 2022-09-30 | ¥218.6bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue external | 2022-04-01 → 2022-09-30 | ¥127.4bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥91.2bn |
| Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segments | segment profit | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| Reconciling Itemsreconciling | revenue | 2022-04-01 → 2022-09-30 | −¥149.1bn |
| Reconciling Itemsreconciling | revenue intersegment | 2022-04-01 → 2022-09-30 | −¥149.1bn |
| Reconciling Itemsreconciling | segment profit | 2022-04-01 → 2022-09-30 | −¥6.4bn |
| jpcrp040300-q2r_E00808-000Basic Materialsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥599.3bn |
| jpcrp040300-q2r_E00808-000Basic Materialsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥576.1bn |
| jpcrp040300-q2r_E00808-000Basic Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥23.2bn |
| jpcrp040300-q2r_E00808-000Basic Materialsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥17.4bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥203.1bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥203.1bn |
| jpcrp040300-q2r_E00808-000Health Carereportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.5bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥573.7bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥569.3bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.4bn |
| jpcrp040300-q2r_E00808-000Industrial Gasesreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥54.3bn |
| jpcrp040300-q2r_E00808-000MMAreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥171.3bn |
| jpcrp040300-q2r_E00808-000MMAreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥166.8bn |
| jpcrp040300-q2r_E00808-000MMAreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥4.6bn |
| jpcrp040300-q2r_E00808-000MMAreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥4.8bn |
| jpcrp040300-q2r_E00808-000Specialty Materialsreportable segment | revenue | 2022-04-01 → 2022-09-30 | ¥652.8bn |
| jpcrp040300-q2r_E00808-000Specialty Materialsreportable segment | revenue external | 2022-04-01 → 2022-09-30 | ¥627.1bn |
| jpcrp040300-q2r_E00808-000Specialty Materialsreportable segment | revenue intersegment | 2022-04-01 → 2022-09-30 | ¥25.6bn |
| jpcrp040300-q2r_E00808-000Specialty Materialsreportable segment | segment profit | 2022-04-01 → 2022-09-30 | ¥43.6bn |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 969
| Item | Context | Value | Unit |
|---|---|---|---|
| Revenue from external customers IFRS | CurrentYTDDuration | 2149898000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000SpecialtyMaterialsReportableSegmentMember | 25601000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000IndustrialGasesReportableSegmentMember | 4336000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000HealthCareReportableSegmentMember | 67000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000MMAReportableSegmentMember | 6059000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000BasicMaterialsReportableSegmentMember | 19978000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 73888000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -129929000000 | JPY |
| Intersegment revenue IFRS | CurrentYTDDuration | - | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000SpecialtyMaterialsReportableSegmentMember | 608331000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000IndustrialGasesReportableSegmentMember | 612572000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000HealthCareReportableSegmentMember | 219398000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000MMAReportableSegmentMember | 144428000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000BasicMaterialsReportableSegmentMember | 511323000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 183775000000 | JPY |
| Revenue IFRS | CurrentYTDDuration_ReconcilingItemsMember | -129929000000 | JPY |
| Revenue IFRS | CurrentYTDDuration | 2149898000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000SpecialtyMaterialsReportableSegmentMember | 17117000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000IndustrialGasesReportableSegmentMember | 80271000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000HealthCareReportableSegmentMember | 32398000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000MMAReportableSegmentMember | 1668000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_jpcrp040300-q2r_E00808-000BasicMaterialsReportableSegmentMember | -12578000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember | 6696000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration_ReconcilingItemsMember | -6008000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration | 119564000000 | JPY |
| Segment profit loss IFRS | Prior1YTDDuration | 122621000000 | JPY |
| Segment profit loss IFRS | CurrentYTDDuration | 119564000000 | JPY |
| Gain on sale of investments in subsidiaries and associates adjustments to profit before tax IFRS | Prior1YTDDuration | - | JPY |
| Gain on sale of investments in subsidiaries and associates adjustments to profit before tax IFRS | CurrentYTDDuration | 7351000000 | JPY |
| Gain on reversal of asset retirement obligations IFRS | Prior1YTDDuration | - | JPY |
| Gain on reversal of asset retirement obligations IFRS | CurrentYTDDuration | 2639000000 | JPY |
| Gain on reversal of environmental expenses IFRS | Prior1YTDDuration | 2389000000 | JPY |
| Gain on reversal of environmental expenses IFRS | CurrentYTDDuration | 60000000 | JPY |
| Impairment losses adjustments to profit before tax IFRS | Prior1YTDDuration | 1894000000 | JPY |
| Impairment losses adjustments to profit before tax IFRS | CurrentYTDDuration | 3186000000 | JPY |
| Loss on liquidation of business IFRS | Prior1YTDDuration | 146000000 | JPY |
| Loss on liquidation of business IFRS | CurrentYTDDuration | 2741000000 | JPY |
| Loss on sale and retirement of fixed assets adjustments to profit before tax IFRS | Prior1YTDDuration | 1411000000 | JPY |
| Loss on sale and retirement of fixed assets adjustments to profit before tax IFRS | CurrentYTDDuration | 1267000000 | JPY |
| Loss on arbitration award IFRS | Prior1YTDDuration | 3502000000 | JPY |
| Loss on arbitration award IFRS | CurrentYTDDuration | 266000000 | JPY |
| Other adjustments to profit before tax IFRS | Prior1YTDDuration | -295000000 | JPY |
| Other adjustments to profit before tax IFRS | CurrentYTDDuration | -16464000000 | JPY |
| Operating profit loss IFRS | Prior1YTDDuration | 118352000000 | JPY |
| Operating profit loss IFRS | CurrentYTDDuration | 138618000000 | JPY |
| Finance income IFRS | Prior1YTDDuration | 16538000000 | JPY |
| Finance income IFRS | CurrentYTDDuration | 14737000000 | JPY |
| Finance costs IFRS | Prior1YTDDuration | 12923000000 | JPY |
| Finance costs IFRS | CurrentYTDDuration | 23204000000 | JPY |
| Profit loss before tax IFRS | Prior1YTDDuration | 121967000000 | JPY |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 16 of 16 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |